Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

DELPHI Software for the Analysis of TMS-EEG Data of Brain Functionality - in Subjects at Risk for Stroke and Dementia

NCT03884647 is registered in ClinicalTrials.gov with QuantalX Neuroscience as lead sponsor.

NCT NCT03884647
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03884647 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
DELPHI Software for the Analysis of TMS-EEG Data of Brain Functionality - in Subjects at Risk for Stroke and Dementia
Lead sponsor
QuantalX Neuroscience
Phase
Observational
Overall status
Completed
Start date
April 1, 2020
Completion date
May 6, 2022
Enrollment
335 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation, cardiac disease, cognitive impairment, diabete mellitus, dyslipidemias, familial alzheimer disease, hypertension, overweight and obesity, sleep disorder, smoking, stroke, transient ischemic attack